{"id":"https://openalex.org/W2014780604","doi":"https://doi.org/10.1016/s0008-6363(95)00057-7","title":"Effects of OPC-18790, a new positive inotropic agent, on energetics in the ischaemic canine heart: a 31P-MRS study","display_name":"Effects of OPC-18790, a new positive inotropic agent, on energetics in the ischaemic canine heart: a 31P-MRS study","publication_year":1995,"publication_date":"1995-08-01","ids":{"openalex":"https://openalex.org/W2014780604","doi":"https://doi.org/10.1016/s0008-6363(95)00057-7","mag":"2014780604","pmid":"https://pubmed.ncbi.nlm.nih.gov/7585818"},"language":"en","primary_location":{"id":"doi:10.1016/s0008-6363(95)00057-7","doi":"https://doi.org/10.1016/s0008-6363(95)00057-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0008-6363(95)00057-7","pdf_url":null,"source":{"id":"https://openalex.org/S91067379","display_name":"Cardiovascular Research","issn_l":"0008-6363","issn":["0008-6363","1755-3245"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067392744","display_name":"Makoto Ishikawa","orcid":"https://orcid.org/0000-0002-1808-1799","observed_orcids":["https://orcid.org/0000-0002-1808-1799"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ishikawa","raw_affiliation_strings":["b Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":[]},{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008443621","display_name":"Tovoki Mori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"T. Mori","raw_affiliation_strings":["b Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":[]},{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113166475","display_name":"Shimpei Itoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S. Itoh","raw_affiliation_strings":["a 2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., 463\u201310 Kagasuno, Kawauchi-cho, Tokushima 771\u201301, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a 2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]},{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., 463\u201310 Kagasuno, Kawauchi-cho, Tokushima 771\u201301, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028634203","display_name":"Hirota Fujiki","orcid":"https://orcid.org/0000-0002-1512-3551","observed_orcids":["https://orcid.org/0000-0002-1512-3551"]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"H. Fujiki","raw_affiliation_strings":["a 2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., 463\u201310 Kagasuno, Kawauchi-cho, Tokushima 771\u201301, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a 2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]},{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., 463\u201310 Kagasuno, Kawauchi-cho, Tokushima 771\u201301, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112320991","display_name":"K. Koga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. Koga","raw_affiliation_strings":["b Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":[]},{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Tominaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Tominaga","raw_affiliation_strings":["a 2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., 463\u201310 Kagasuno, Kawauchi-cho, Tokushima 771\u201301, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a 2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]},{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., 463\u201310 Kagasuno, Kawauchi-cho, Tokushima 771\u201301, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"last","author":{"id":null,"display_name":"Y. Yabuuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Yabuuchi","raw_affiliation_strings":["b Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":[]},{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5008443621"],"corresponding_institution_ids":["https://openalex.org/I114030911"],"apc_list":{"value":4715,"currency":"EUR","value_usd":5329},"apc_paid":null,"fwci":1.824,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.85516983,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"30","issue":"2","first_page":"299","last_page":"306"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.7163000106811523,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.7163000106811523,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.11550000309944153,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10372","display_name":"Cardiac Imaging and Diagnostics","score":0.04399999976158142,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/positive-inotropic-agents","display_name":"positive inotropic agents","score":0.8659999966621399},{"id":"https://openalex.org/keywords/myocardial-ischemia","display_name":"myocardial ischemia","score":0.8500000238418579},{"id":"https://openalex.org/keywords/myocardial-energy-metabolism","display_name":"myocardial energy metabolism","score":0.8130000233650208},{"id":"https://openalex.org/keywords/amrinone","display_name":"amrinone","score":0.7239999771118164},{"id":"https://openalex.org/keywords/phosphodiesterase-inhibition","display_name":"phosphodiesterase inhibition","score":0.7319999933242798},{"id":"https://openalex.org/keywords/cgmp","display_name":"cyclic GMP","score":0.6240000128746033},{"id":"https://openalex.org/keywords/intracellular-acidosis","display_name":"intracellular acidosis","score":0.9169999957084656},{"id":"https://openalex.org/keywords/coronary-blood-flow","display_name":"coronary blood flow","score":0.8420000076293945},{"id":"https://openalex.org/keywords/regional-myocardial-contractility","display_name":"regional myocardial contractility","score":0.7940000295639038},{"id":"https://openalex.org/keywords/hemodynamics","display_name":"hemodynamics","score":0.75},{"id":"https://openalex.org/keywords/ischemic-heart-failure","display_name":"ischemic heart failure","score":0.8740000128746033},{"id":"https://openalex.org/keywords/31p-nmr-spectroscopy","display_name":"31P NMR","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C155710745","wikidata":"https://www.wikidata.org/wiki/Q575278","display_name":"Inotrope","level":2,"score":0.7698854207992554},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6167095303535461},{"id":"https://openalex.org/C97514900","wikidata":"https://www.wikidata.org/wiki/Q719597","display_name":"Energetics","level":2,"score":0.6101182103157043},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5585247278213501},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5003142356872559},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11755311489105225},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000676","descriptor_name":"Amrinone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003326","descriptor_name":"Coronary Circulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004734","descriptor_name":"Energy Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009200","descriptor_name":"Myocardial Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017202","descriptor_name":"Myocardial Ischemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0008-6363(95)00057-7","doi":"https://doi.org/10.1016/s0008-6363(95)00057-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0008-6363(95)00057-7","pdf_url":null,"source":{"id":"https://openalex.org/S91067379","display_name":"Cardiovascular Research","issn_l":"0008-6363","issn":["0008-6363","1755-3245"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Research","raw_type":"journal-article"},{"id":"doi:10.1016/0008-6363(95)00057-7","doi":"https://doi.org/10.1016/0008-6363(95)00057-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0008-6363(95)00057-7","pdf_url":null,"source":{"id":"https://openalex.org/S91067379","display_name":"Cardiovascular Research","issn_l":"0008-6363","issn":["0008-6363","1755-3245"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Research","raw_type":"journal-article"},{"id":"pmid:7585818","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7585818","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular research","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2082188995","https://openalex.org/W2017440581","https://openalex.org/W2030495561","https://openalex.org/W2024384450","https://openalex.org/W1965481379","https://openalex.org/W2104801094","https://openalex.org/W2074011439","https://openalex.org/W1969899562","https://openalex.org/W2009124738","https://openalex.org/W2098533846"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Effects":[1],"of":[2,32,47,60,179,239,267],"OPC-18790,":[3],"a":[4,34,89,110],"novel":[5],"positive":[6],"inotropic":[7],"agent,":[8],"on":[9,256],"cardiohaemodynamics":[10],"and":[11,28,73,133,143,194,210,227,248],"cardiac":[12,20,53,93],"energetics":[13],"were":[14,55,78,198],"assessed":[15],"simultaneously":[16,80],"in":[17,92,100,112,118,127,139,174,184,192,196,222,244,264],"dogs":[18],"with":[19,30,52,109,135,164,203],"ischaemia":[21,41,54],"using":[22],"phosphorus-31":[23],"magnetic":[24],"resonance":[25],"spectroscopy":[26],"(31P-MRS)":[27],"compared":[29,163],"those":[31,201],"amrinone,":[33],"pure":[35],"cGMP-inhibited":[36],"PDE":[37],"inhibitor.":[38],"METHODS:":[39],"Cardiac":[40],"was":[42,187],"produced":[43,86,124,171],"by":[44,81,130],"partial":[45],"stenosis":[46,85],"the":[48,58,101,119,156,160,182,190,207,215,230,237,245,265],"coronary":[49,62,114],"artery.":[50],"Dogs":[51],"instrumented":[56],"for":[57],"determination":[59],"regional":[61,69,87,113,152],"blood":[63,115,145],"flow":[64,116],"(non-radioactive":[65],"coloured":[66],"microsphere":[67],"method),":[68],"contractile":[70],"function":[71],"(sonomicrometry),":[72],"haemodynamics.":[74,258],"Myocardial":[75],"phosphate":[76,103,105],"compounds":[77],"measured":[79],"31P-MRS.":[82],"RESULTS:":[83],"Coronary":[84],"dyskinesis,":[88,153],"slight":[90,137],"decrease":[91,111,195],"output":[94],"(CO),":[95],"intracellular":[96,211],"acidosis,":[97],"an":[98,125,172],"increase":[99,126,173,183,191,242],"inorganic":[102],"(Pi)/creatine":[104],"(PCr)":[106],"ratio":[107,158,209],"concomitantly":[108],"(CBF)":[117],"ischaemic":[120,165,246,268],"region.":[121],"OPC-18790":[122,148,226,240,260],"dose-dependently":[123],"contractility":[128],"(measured":[129],"peak":[131,185],"LVdP/dt)":[132],"CO,":[134],"only":[136,213],"changes":[138],"heart":[140,269],"rate":[141],"(HR)":[142],"mean":[144],"pressure":[146],"(mBP).":[147],"did":[149],"not":[150],"change":[151],"but":[154],"improved":[155],"Pi/PCr":[157,208],"at":[159,214,229],"high":[161,216,231],"dose":[162,232],"values":[166],"(before":[167],"drug":[168],"administration).":[169],"Amrinone":[170,205],"CO":[175],"comparable":[176],"to":[177,236,241,252],"that":[178],"OPC-18790;":[180],"however,":[181],"LVdP/dt":[186],"smaller":[188],"while":[189],"HR":[193],"mBP":[197],"larger":[199],"than":[200],"seen":[202],"OPC-18790.":[204],"worsened":[206],"acidosis":[212],"dose.":[217],"CONCLUSION:":[218],"These":[219],"observed":[220],"differences":[221],"energy":[223],"metabolism":[224],"between":[225],"amrinone":[228],"may":[233,250,261],"be":[234,262],"due":[235],"ability":[238],"CBF":[243],"region":[247],"which":[249],"attributed":[251],"its":[253],"differing":[254],"effect":[255],"overall":[257],"Thus,":[259],"useful":[263],"management":[266],"failure.":[270]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}